Article
Committee Opinion No. 545
21 Nov 2012
Abstract excerpt
Noninvasive prenatal testing that uses cell free fetal DNA from the plasma of pregnant women offers tremendous potential as a screening tool for fetal aneuploidy. Cell free fetal DNA testing should be an informed patient choice after pretest counseling and should not be part of routine prenatal laboratory assessment. Cell free fetal DNA testing should not be offered to low-risk women or women with multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
